RGDXQ — Response Genetics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Response Genetics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2010 December 31st	2011 December 31st	2012 December 31st	2013 December 31st	2014 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	4.12	1.7	9.04	8.15	2.22
Net Total Accounts Receivable
Net Total Receivables	4.73	4.05	5.37	6.23	7.81
Prepaid Expenses
Total Current Assets	9.8	6.74	15	15.4	11.2
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.699	1.07	1.02	1.93	1.41
Net Intangible Assets
Other Long Term Assets
Total Assets	10.6	7.85	16.6	18.1	13.4
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	5.92	5.89	5.27	5.66	5.05
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	13.9	14	17.1	12.3	14.6
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-3.28	-6.14	-0.542	5.76	-1.17
Total Liabilities & Shareholders' Equity	10.6	7.85	16.6	18.1	13.4
Total Common Shares Outstanding